Table 2.
Number and proportion of CA1-projecting or mEC-projecting MS/vDB and hDB neurons tested for ChAT and PV immunoreactivitya
| Neurons | Location | All cells tested for ChAT |
ChAT-negative cells tested for PV |
||||
|---|---|---|---|---|---|---|---|
| N | ChAT+ | (%) | N | PV+ | (%) | ||
| CA1-projecting | MS/vDB | 161 | 57 | (35) | 83* | 8 | (10) |
| hDB | 156 | 97 | (62) | 59 | 3 | (5) | |
| Subtotal | 317 | 154 | (49) | 142 | 11 | (8) | |
| mEC-projecting | MS/vDB | 78 | 46 | (59) | 32 | 3 | (9) |
| hDB | 68 | 59 | (87) | 9 | 1 | (11) | |
| Subtotal | 146 | 105 | (72) | 41 | 4 | (10) | |
| Total | 463 | 259 | (56) | 183 | 15 | (8) | |
aNumber and proportion of all retrogradely labeled CA1-projecting or mEC-projecting neurons in MS/vDB and hDB that were tested (N) for ChAT immunoreactivity; the ChAT-immunonegative cells were tested for PV.
*Note that only 83 of 104 ChAT-immunonegative cells were tested for PV.